Spectral Medical (EDT.TO) Stock Price

Spectral Medical Price

TSX·CLOSED
1.40CAD+0.0100 (+0.72 %)
Market closed

Over the last 19 years Spectral Medical grew revenue by 0.6% annually, reaching 2.44 M CAD. For Spectral Medical, the net margin of -1,953.0% is down versus -440.1% a few years ago. The consensus 12-month price target for Spectral Medical is 3.16 CAD, about 125.9% above where the stock trades today. Of 6 analysts, 5 rate the stock a buy — an overall Buy consensus. The stock trades about 73% above its 52-week low.

Spectral Medical stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Spectral Medical over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Spectral Medical stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Spectral Medical's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Spectral Medical Stock Price History
DateSpectral Medical Price
7/30/20261.40 CAD
7/29/20261.39 CAD
7/28/20261.37 CAD
7/27/20261.38 CAD
7/24/20261.35 CAD
7/23/20261.38 CAD
7/22/20261.35 CAD
7/21/20261.40 CAD
7/20/20261.40 CAD
7/17/20261.42 CAD
7/16/20261.37 CAD
7/15/20261.35 CAD
7/14/20261.36 CAD
7/13/20261.37 CAD
7/10/20261.35 CAD
7/9/20261.34 CAD
7/8/20261.35 CAD
7/7/20261.33 CAD
7/6/20261.36 CAD
7/3/20261.34 CAD
7/2/20261.34 CAD
6/30/20261.32 CAD
6/29/20261.32 CAD
6/26/20261.36 CAD
6/25/20261.35 CAD
6/24/20261.35 CAD
6/23/20261.36 CAD
6/22/20261.36 CAD
6/19/20261.36 CAD
6/18/20261.36 CAD
6/17/20261.38 CAD
6/16/20261.38 CAD
6/15/20261.39 CAD
6/12/20261.38 CAD
6/11/20261.37 CAD
6/10/20261.37 CAD
6/9/20261.38 CAD
6/8/20261.39 CAD
6/5/20261.38 CAD
6/4/20261.41 CAD
6/3/20261.39 CAD
6/2/20261.39 CAD
6/1/20261.41 CAD
5/29/20261.42 CAD
5/28/20261.40 CAD
5/27/20261.42 CAD
5/26/20261.42 CAD
5/25/20261.43 CAD
5/22/20261.42 CAD
5/21/20261.38 CAD
5/20/20261.38 CAD
5/19/20261.37 CAD
5/15/20261.40 CAD
5/14/20261.41 CAD
5/13/20261.44 CAD
5/12/20261.40 CAD
5/11/20261.40 CAD
5/8/20261.43 CAD
5/7/20261.36 CAD
5/6/20261.40 CAD
5/5/20261.39 CAD
5/4/20261.42 CAD
5/1/20261.36 CAD
4/30/20261.35 CAD
4/29/20261.33 CAD
4/28/20261.38 CAD
4/27/20261.38 CAD
4/24/20261.40 CAD
4/23/20261.37 CAD
4/22/20261.36 CAD
4/21/20261.36 CAD
4/20/20261.37 CAD
4/17/20261.39 CAD
4/16/20261.38 CAD
4/15/20261.39 CAD
4/14/20261.39 CAD
4/13/20261.38 CAD
4/10/20261.40 CAD
4/9/20261.38 CAD
4/8/20261.36 CAD
4/7/20261.40 CAD
4/6/20261.47 CAD
4/2/20261.42 CAD
4/1/20261.42 CAD
3/31/20261.39 CAD
3/30/20261.40 CAD
3/27/20261.43 CAD
3/26/20261.43 CAD
3/25/20261.46 CAD
3/24/20261.46 CAD
3/23/20261.33 CAD
3/20/20261.25 CAD
3/19/20261.28 CAD
3/18/20261.31 CAD
3/17/20261.28 CAD
3/16/20261.28 CAD
3/13/20261.29 CAD
3/12/20261.28 CAD
3/11/20261.31 CAD
3/10/20261.32 CAD
3/9/20261.30 CAD
3/6/20261.31 CAD
3/5/20261.32 CAD
3/4/20261.31 CAD
3/3/20261.32 CAD
3/2/20261.34 CAD
2/27/20261.31 CAD
2/26/20261.36 CAD
2/25/20261.39 CAD
2/24/20261.37 CAD
2/23/20261.38 CAD
2/20/20261.35 CAD
2/19/20261.37 CAD
2/18/20261.29 CAD
2/17/20261.28 CAD
2/13/20261.30 CAD
2/12/20261.31 CAD
2/11/20261.30 CAD
2/10/20261.31 CAD
2/9/20261.30 CAD
2/6/20261.30 CAD
2/5/20261.30 CAD
2/4/20261.35 CAD
2/3/20261.32 CAD
2/2/20261.32 CAD
1/30/20261.25 CAD
1/29/20261.32 CAD
1/28/20261.30 CAD
1/27/20261.32 CAD
1/26/20261.32 CAD
1/23/20261.34 CAD
1/22/20261.29 CAD
1/21/20261.32 CAD
1/20/20261.34 CAD
1/19/20261.37 CAD
1/16/20261.37 CAD
1/15/20261.41 CAD
1/14/20261.46 CAD
1/13/20261.46 CAD
1/12/20261.44 CAD
1/9/20261.45 CAD
1/8/20261.40 CAD
1/7/20261.39 CAD
1/6/20261.39 CAD
1/5/20261.41 CAD
1/2/20261.38 CAD
12/31/20251.44 CAD
12/30/20251.31 CAD
12/29/20251.30 CAD
12/24/20251.27 CAD
12/23/20251.27 CAD
12/22/20251.29 CAD
12/19/20251.27 CAD
12/18/20251.27 CAD
12/17/20251.31 CAD
12/16/20251.29 CAD
12/15/20251.28 CAD
12/12/20251.27 CAD
12/11/20251.27 CAD
12/10/20251.28 CAD
12/9/20251.31 CAD
12/8/20251.32 CAD
12/5/20251.27 CAD
12/4/20251.27 CAD
12/3/20251.27 CAD
12/2/20251.24 CAD
12/1/20251.25 CAD
11/28/20251.33 CAD
11/27/20251.28 CAD
11/26/20251.28 CAD
11/25/20251.32 CAD
11/24/20251.28 CAD
11/21/20251.34 CAD
11/20/20251.33 CAD
11/19/20251.36 CAD
11/18/20251.38 CAD
11/17/20251.38 CAD
11/14/20251.41 CAD
11/13/20251.35 CAD
11/12/20251.42 CAD
11/11/20251.46 CAD
11/10/20251.50 CAD
11/7/20251.43 CAD
11/6/20251.44 CAD
11/5/20251.43 CAD
11/4/20251.43 CAD
11/3/20251.47 CAD
10/31/20251.48 CAD
10/30/20251.51 CAD
10/29/20251.56 CAD
10/28/20251.55 CAD
10/27/20251.57 CAD
10/24/20251.54 CAD
10/23/20251.57 CAD
10/22/20251.61 CAD
10/21/20251.53 CAD
10/20/20251.58 CAD
10/17/20251.53 CAD
10/16/20251.59 CAD
10/15/20251.43 CAD
10/14/20251.42 CAD
10/10/20251.40 CAD
10/9/20251.42 CAD
10/8/20251.41 CAD
10/7/20251.44 CAD
10/6/20251.44 CAD
10/3/20251.45 CAD
10/2/20251.37 CAD
10/1/20251.44 CAD
9/30/20251.46 CAD
9/29/20251.52 CAD
9/26/20251.47 CAD
9/25/20251.48 CAD
9/24/20251.46 CAD
9/23/20251.48 CAD
9/22/20251.44 CAD
9/19/20251.48 CAD
9/18/20251.48 CAD
9/17/20251.48 CAD
9/16/20251.56 CAD
9/15/20251.63 CAD
9/12/20251.70 CAD
9/11/20251.70 CAD
9/10/20251.73 CAD
9/9/20251.70 CAD
9/8/20251.75 CAD
9/5/20251.63 CAD
9/4/20251.59 CAD
9/3/20251.59 CAD
9/2/20251.57 CAD
8/29/20251.49 CAD
8/28/20251.48 CAD
8/27/20251.43 CAD
8/26/20251.36 CAD
8/25/20251.40 CAD
8/22/20251.40 CAD
8/21/20251.26 CAD
8/20/20251.13 CAD
8/19/20251.12 CAD
8/18/20251.11 CAD
8/15/20251.10 CAD
8/14/20251.09 CAD
8/13/20251.09 CAD
8/12/20250.82 CAD
8/11/20250.81 CAD
8/8/20250.81 CAD
8/7/20250.82 CAD
8/6/20250.83 CAD
8/5/20250.82 CAD
Access this data via the Eulerpool API
Get Free API Key

Spectral Medical Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
1.60 M CAD
-14.17 M CAD
-15.66 M CAD
Jan 1, 2024
2.29 M CAD
-12.22 M CAD
-15.40 M CAD
Jan 1, 2025
2.44 M CAD
-11.69 M CAD
-47.69 M CAD
Jan 1, 2026 (e)
2.81 M CAD
-2.81 M CAD
-9.22 M CAD
Jan 1, 2027 (e)
13.75 M CAD
-13.75 M CAD
0.00 CAD
Jan 1, 2028 (e)
47.79 M CAD
-47.79 M CAD
19.68 M CAD
Jan 1, 2029 (e)
136.87 M CAD
-136.87 M CAD
56.22 M CAD
Jan 1, 2030 (e)
199.73 M CAD
-199.73 M CAD
89.95 M CAD

Spectral Medical Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 4, 2026, 12:17 PM
 
REVENUEM CAD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM CAD
EBITM CAD
EBIT MARGIN%
NET INCOMEM CAD
NET INCOME GROWTH%
SHARESM
201520162017201820192020202120222023202420252026e2027e2028e2029e2030e
3.003.003.003.002.002.001.001.001.002.002.002.0013.0047.00136.00199.00
50.00–––-33.33–-50.00––100.00––550.00261.54189.3646.32
66.6766.67100.00100.00100.0050.00100.00-500.00-500.0050.00-250.00-250.00-250.00-250.00-250.00-250.00
2.002.003.003.002.001.001.00-5.00-5.001.00-5.00-5.00-32.50-117.50-340.00-497.50
-9.00-10.00-3.00-2.00-4.00-9.00-6.00-8.00-14.00-12.00-11.00-2.00-13.00-47.00-136.00-199.00
-300.00-333.33-100.00-66.67-200.00-450.00-600.00-800.00-1,400.00-600.00-550.00-100.00-100.00-100.00-100.00-100.00
-9.00-10.00-4.00-2.00-4.00-9.00-8.00-11.00-15.00-15.00-47.00-9.00–19.0056.0089.00
–11.11-60.00-50.00100.00125.00-11.1137.5036.36–213.33-80.85––194.7458.93
190.75207.07207.45225.59225.84225.84256.70269.84278.54283.49291.70291.70291.70291.70291.70291.70
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Spectral Medical generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Spectral Medical retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Spectral Medical's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Spectral Medical has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Spectral Medical's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Spectral Medical stock margins

The Spectral Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Spectral Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Spectral Medical.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
58.32 %
-334.12 %
-440.13 %
Jan 1, 2022
58.97 %
-506.72 %
-676.72 %
Jan 1, 2023
41.43 %
-886.92 %
-980.10 %
Jan 1, 2024
44.53 %
-534.47 %
-673.75 %
Jan 1, 2025
-211.14 %
-478.50 %
-1,952.99 %
Jan 1, 2026 (e)
-211.14 %
-100.00 %
-328.43 %
Jan 1, 2027 (e)
-211.14 %
-100.00 %
0.00 %
Jan 1, 2028 (e)
-211.14 %
-100.00 %
41.17 %

Spectral Medical Stock Revenue, EBIT, Earnings per Share

The Spectral Medical earnings per share therefore indicates how much revenue Spectral Medical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
0.01 CAD
-0.03 CAD
-0.03 CAD
Jan 1, 2022
0.01 CAD
-0.03 CAD
-0.04 CAD
Jan 1, 2023
0.01 CAD
-0.05 CAD
-0.06 CAD
Jan 1, 2024
0.01 CAD
-0.04 CAD
-0.05 CAD
Jan 1, 2025
0.01 CAD
-0.04 CAD
-0.16 CAD
Jan 1, 2026 (e)
0.01 CAD
-0.01 CAD
-0.03 CAD
Jan 1, 2027 (e)
0.05 CAD
-0.05 CAD
0.00 CAD
Jan 1, 2028 (e)
0.17 CAD
-0.16 CAD
0.07 CAD

Spectral Medical business model & stock analysis

Spectral Medical Inc. is a Canadian health company specializing in the development of diagnostic and monitoring technologies for severe diseases and conditions. Established in 1991, Spectral Medical has made a name for itself in the pharmaceutical industry.

Spectral Medical SWOT Analysis

Strengths

1. Strong Research and Development capabilities: Spectral Medical Inc has established a robust research and development department, enabling them to innovate and develop advanced medical technologies.

2. Patented products: The company owns multiple patented technologies, providing a competitive advantage and protecting their intellectual property.

3. Strategic partnerships: Spectral Medical Inc has formed strategic partnerships with leading healthcare organizations, enhancing their market presence and facilitating product development.

Weaknesses

1. Limited market presence: Spectral Medical Inc's products are currently available in a limited number of markets, which may restrict their revenue potential.

2. Dependency on key personnel: The company's success is closely tied to the expertise and contributions of key individuals, which poses a risk in terms of succession planning and talent retention.

3. Regulatory hurdles: As a medical technology company, Spectral Medical Inc must navigate stringent regulatory processes, potentially leading to delays in product approvals and commercialization.

Opportunities

1. Growing demand for innovative medical solutions: With an aging population and increasing healthcare needs, there is a significant opportunity for Spectral Medical Inc to tap into the rising demand for advanced medical technologies.

2. Expansion into new markets: The company can explore untapped international markets, thereby diversifying their revenue streams and reducing dependency on any single market.

3. Collaborations with academic institutions: Partnering with academic institutions can provide access to cutting-edge research and specialized expertise, enabling Spectral Medical Inc to further enhance their products and offerings.

Threats

1. Intense competition: Spectral Medical Inc operates in a highly competitive industry, facing competition from established medical technology companies as well as emerging startups.

2. Economic volatility: Any economic downturn or instability can potentially impact the purchasing power of healthcare providers and lead to a decline in demand for medical technologies.

3. Stringent regulatory environment: Compliance with complex and ever-changing regulations can pose challenges for Spectral Medical Inc, including higher costs and delays in product launches.

Spectral Medical Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Spectral Medical historical P/E ratio, EBIT multiple, and P/S ratio

Spectral Medical annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Spectral Medical shares outstanding

The number of shares of Spectral Medical was 291.7 M in 2025. This indicates how many shares Spectral Medical is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
256.70 M Stocks
Jan 1, 2022
269.84 M Stocks
Jan 1, 2023
278.54 M Stocks
Jan 1, 2024
283.49 M Stocks
Jan 1, 2025
291.70 M Stocks
Jan 1, 2026 (e)
291.70 M Stocks
Jan 1, 2027 (e)
291.70 M Stocks
Jan 1, 2028 (e)
291.70 M Stocks

Current Spectral Medical forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
83.33 % (5)
Hold
16.67 % (1)
Sell
0.00 % (0)
12M Price Target
3.16
Last Price
1.40
Currency
CAD
12M Return Potential
125.86 %
LTM Return
0 %

Spectral Medical Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
3/22/2024-0.01CAD-707,000.00CAD-2023 Q4
3/22/2023-0.01CAD-608,999.00CAD-2022 Q4
11/10/2022-0.01CAD-405,999.00CAD-2022 Q3
8/12/2022-0.01CAD-608,999.00CAD-2022 Q2
5/13/2022-0.01CAD-608,999.00CAD-2022 Q1
3/24/2022-0.01CAD-507,499.00CAD-2021 Q4
11/12/2021-0.01CAD-608,999.00CAD-2021 Q3
8/13/2021-0.01CAD-507,499.00CAD-2021 Q2
5/14/2021-0.01CAD-608,999.00CAD-2021 Q1
3/26/2021-0.01CAD-507,499.00CAD-2020 Q4

Spectral Medical shareholder structure

% Name
16.23384%
Toray Industries Inc
Toray Industries Inc
12.88245%
Birch Hill Equity Partners Management Inc.
Birch Hill Equity Partners Management Inc.
0.66844%
Walker (Paul M)
Walker (Paul M)
0.41443%
Seto (Chris)
Seto (Chris)
0.31857%
Stevens (William Charles)
Stevens (William Charles)
0.04198%
Palos Management Inc.
Palos Management Inc.

Spectral Medical Beneficial Ownership Filings (SEC 13D/G)

Free Float
70.5%
Float Shares
-
Shares Outstanding
-

Spectral Medical Executives and Management Board

10 members · avg. age 67 · 20 % women

CS

Mr. Chris Seto

Chief Executive Officer, Chief Financial Officer, Director · since 2019

1.10 M CAD

Management

JK

Mr. John Kellum

Chief Medical Officer

815,179.00 CAD
PW

Dr. Paul Walker

Chairman of the Board, President · since 2001

113,875.00 CAD
MG

Mrs. Medha Gupta

Vice President - Finance

–
AM

Mr. Ali Mahdavi

Investor Relations · since 2019

–

Board of Directors

JD

Ms. Janelle D'Alvise (67)

Independent Director

114,988.00 CAD
DF

Dr. David Feigal

Independent Director

108,258.00 CAD
WS

Mr. William Stevens

Independent Director

108,250.00 CAD
CF

Mr. Cristiano Franzi

Director

78,016.00 CAD
JH

Mr. Jun Hayakawa

Independent Director

–

Spectral Medical Supply Chain

Spectral Medical Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
4 companies
#NameTrend
1
Danaher
Supplier·Customer·Life Sciences Tools & Services·US
-0.88
-0.19
0.34
-0.54
-0.35
-0.72
2
Abbott Laboratories
Supplier·Customer·Health Care Equipment & Supplies·US
-0.73
-0.20
0.50
-0.58
-0.52
-0.49
3
Toray Industries
Supplier·Customer·Chemicals·JP
-0.62
-0.51
-0.41
-0.48
0.26
-0.21
4
Baxter Intl
Customer·Health Care Equipment & Supplies·US
-0.12
-0.48
0.63
-0.18
0
0.24

Frequently asked questions about Spectral Medical

The business model of Spectral Medical Inc revolves around developing and commercializing innovative diagnostic and therapeutic solutions for patients with septic shock and other acute medical conditions. Spectral Medical focuses on providing personalized medicine through its proprietary Endotoxin Activity Assay (EAATM) and Toraymyxin (PMXTM) products. By utilizing advanced technologies, Spectral Medical aims to improve patient outcomes and reduce healthcare costs associated with septic shock. This Canadian company is dedicated to addressing the significant unmet medical needs in critically ill patients through groundbreaking solutions for the detection and treatment of severe infections.

Spectral Medical Inc is primarily active in the healthcare industry.

The main competitors of Spectral Medical Inc in the market include companies such as Baxter International Inc, Fresenius Medical Care AG & Co KGaA, and Becton, Dickinson and Company.

Spectral Medical Inc is a leading biotechnology company specializing in the development and commercialization of innovative solutions for patient care. Founded in 1991, the company has a rich history of advancing critical care and medical technology. With a focus on improving outcomes for patients experiencing septic shock, Spectral Medical Inc has developed the Endotoxin Activity Assay (EAA™) diagnostic platform. This platform helps physicians make informed treatment decisions by measuring the level of endotoxin, a toxin present in the bloodstream during sepsis. Spectral Medical Inc's dedication to research and development has led to groundbreaking advancements in the field of sepsis management, making it a prominent player in the healthcare industry.

Spectral Medical Inc has achieved several significant milestones throughout its history. Notably, the company developed and commercialized its flagship product, the Spectral Apheresis Machine (SAM), which received regulatory approval in multiple jurisdictions. It successfully completed clinical trials and obtained clearance from the U.S. FDA for the use of SAM in critically ill patients with septic shock. Moreover, Spectral Medical Inc has collaborated with leading medical centers and research institutions to further validate the efficacy of SAM. These achievements highlight the company's commitment to advancing critical care medicine and improving patient outcomes.

Spectral Medical Inc is primarily present in multiple countries and regions. The company has a significant presence in Canada, where it is headquartered, and operates in various provinces and territories across the country. Additionally, Spectral Medical Inc has expanded its operations internationally. The company is also present in the United States, focusing on key states such as California, New York, and Texas. Furthermore, Spectral Medical Inc has established its presence in European countries, including Germany, France, and the United Kingdom. With its global reach and expanding market presence, Spectral Medical Inc continues to serve customers and stakeholders in diverse countries and regions worldwide.

Spectral Medical Inc represents a set of core values and corporate philosophy that drive its mission and operations. Committed to advancing the field of critical care medicine, Spectral Medical Inc upholds principles of innovation, collaboration, and patient-centricity. The company prioritizes research and development to provide cutting-edge medical solutions for the diagnosis and treatment of life-threatening conditions. By leveraging advanced technology and expertise, Spectral Medical Inc strives to improve patient outcomes and enhance healthcare practices. As a leader in its field, the company continuously pursues excellence, integrity, and a steadfast commitment to delivering valuable solutions for critical care patients.

Analysts currently set an average price target of 3.16 CAD for the Spectral Medical stock (median: 3.16 CAD), implying +125.9 % versus the latest price. The consensus is based on 6 analyst ratings.

Spectral Medical Analyst Price Targets 2026

6 analysts currently rate the Spectral Medical stock: 5 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Spectral Medical to generate revenue of 2.81 M CAD and earnings per share of -0.03 CAD.

Spectral Medical Analyst Price Targets 2026

Converted at the current exchange rate, the Spectral Medical share trades at 0.87 EUR (1.40 CAD).

The Spectral Medical share (EDT.TO) is listed on 3 stock exchanges, including: Frankfurt (SD4.F), Toronto (EDT.TO).

Spectral Medical Inc. is a leading company in the field of diagnostic tests and treatment of severe diseases in intensive care medicine. The company is headquartered in Toronto, Canada and is listed on the Toronto Stock Exchange. The business model of Spectral Medical Inc. focuses on the development, production, and marketing of products and solutions that contribute to the improvement of the treatment of patients in critical conditions. The company operates two main divisions, namely the Therapeutic Division and the Diagnostic Division. Both divisions produce products that focus on the diagnosis and treatment of patients in intensive care. The Therapeutic Division of Spectral Medical Inc. produces products known as Apheresis Systems. These systems are used for the removal of toxins and excess fluids from the patient's blood. The blood is passed through the system and the unwanted substances are removed. The clean blood fluid is then returned to the patient's body. The Apheresis System has proven to be an effective treatment for patients suffering from severe diseases such as sepsis and multiorgan failure. The Diagnostic Division of Spectral Medical Inc. produces products known as endotoxin tests. Endotoxins are produced by the breakdown of bacteria and are recognized by the body as harmful substances. The endotoxin tests by Spectral Medical Inc. are used for rapid and accurate diagnosis of sepsis, a life-threatening disease caused by an infection. Spectral Medical Inc. is also committed to advancing research and development in the field of intensive care medicine. The company has close relationships with leading medical research institutions and works closely with intensivists to find innovative solutions to industry challenges. The business model of Spectral Medical Inc. is based on strategic partnerships with key players in the healthcare industry, such as hospitals, clinics, and research institutes. The company aims to provide its customers with first-class products and services and to offer them a comprehensive medical solution. In summary, Spectral Medical Inc. is a company that focuses on the development and marketing of solutions that contribute to the improvement of intensive care medicine. The company offers products that help save patients' lives by combating life-threatening diseases such as sepsis and multiorgan failure. Spectral Medical Inc. aims to find innovative solutions to the most serious problems in intensive care medicine and to support its customers with first-class products and services.

The expected revenue of Spectral Medical is 2.81 M CAD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Spectral Medical is -9.22 M CAD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Spectral Medical is currently -44.30. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Spectral Medical stock.

The price-to-sales ratio (P/S) of Spectral Medical is currently 145.48. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Spectral Medical stock.

The Eulerpool Quality Score for Spectral Medical is 3/10.

The ISIN of Spectral Medical is CA8475771033. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Spectral Medical is A12HJ9. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Spectral Medical is EDT.TO. The ticker symbol is used to trade Spectral Medical shares on the stock exchange.

Spectral Medical paid dividends every year for the past 0 years.

Spectral Medical is assigned to the 'Health' sector.

The dividends of Spectral Medical are distributed in CAD.

All fundamentals and in-depth analysis of Spectral Medical

Our stock analysis for Spectral Medical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Spectral Medical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Spectral Medical Stock
Spectral Medical Revenue→
Spectral Medical Stock
Spectral Medical Net Income→
Spectral Medical Stock
Spectral Medical P/E→
Spectral Medical Stock
Spectral Medical P/S→
Spectral Medical Stock
Spectral Medical EBIT→
Spectral Medical Stock
Spectral Medical Dividend→
Spectral Medical Stock
Spectral Medical Directors Dealings→
Spectral Medical Stock
Spectral Medical Stocks→
Spectral Medical Stock
Spectral Medical Market capitalization→
Spectral Medical Stock
Spectral Medical Debt→
Spectral Medical Stock
Spectral Medical Liabilities→
Spectral Medical Stock
Spectral Medical Equity→
Spectral Medical Stock
Spectral Medical AAQS→
Spectral Medical Stock
Spectral Medical Employees→
Spectral Medical Stock
Spectral Medical ROE→
Spectral Medical Stock
Spectral Medical ROA→
Spectral Medical Stock
Spectral Medical ROCE→
Spectral Medical Stock
Spectral Medical News→
Spectral Medical Stock
Spectral Medical Analyst Price Targets→

Health Stocks

Speed Medical SAESpectral AISpeedusSpectraCure AB (publ)Spero TherapeuticsSpecialized Medical Company SCJSCSphereSpago Nanomedical AB (publ)SpineguardSource Natural Foods and Herbal SupplementsSpinewaySotera HealthAll Stocks A–Z →